Cargando…

Reduction of Conduction Velocity in Patients with Atrial Fibrillation

It is unknown to what extent atrial fibrillation (AF) episodes affect intra-atrial conduction velocity (CV) and whether regional differences in local CV heterogeneities exist during sinus rhythm. This case-control study aims to compare CV assessed throughout both atria between patients with and with...

Descripción completa

Detalles Bibliográficos
Autores principales: Heida, Annejet, van Schie, Mathijs S., van der Does, Willemijn F. B., Taverne, Yannick J. H. J., Bogers, Ad J. J. C., de Groot, Natasja M. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231908/
https://www.ncbi.nlm.nih.gov/pubmed/34198544
http://dx.doi.org/10.3390/jcm10122614
_version_ 1783713523123093504
author Heida, Annejet
van Schie, Mathijs S.
van der Does, Willemijn F. B.
Taverne, Yannick J. H. J.
Bogers, Ad J. J. C.
de Groot, Natasja M. S.
author_facet Heida, Annejet
van Schie, Mathijs S.
van der Does, Willemijn F. B.
Taverne, Yannick J. H. J.
Bogers, Ad J. J. C.
de Groot, Natasja M. S.
author_sort Heida, Annejet
collection PubMed
description It is unknown to what extent atrial fibrillation (AF) episodes affect intra-atrial conduction velocity (CV) and whether regional differences in local CV heterogeneities exist during sinus rhythm. This case-control study aims to compare CV assessed throughout both atria between patients with and without AF. Patients (n = 34) underwent intra-operative epicardial mapping of the right atrium (RA), Bachmann’s bundle (BB), left atrium (LA) and pulmonary vein area (PVA). CV vectors were constructed to calculate median CV in addition to total activation times (TAT) and unipolar voltages. Biatrial median CV did not differ between patients with and without AF (90 ± 8 cm/s vs. 92 ± 6 cm/s, p = 0.56); only BB showed a CV reduction in the AF group (79 ± 12 cm/s vs. 88 ± 11 cm/s, p = 0.02). In patients without AF, there was no predilection site for the lowest CV (P(5)) (RA: 12%; BB: 29%; LA: 29%; PVA: 29%). In patients with AF, lowest CV was most often measured at BB (53%) and ranged between 15 to 22 cm/s (median: 20 cm/s). Lowest CVs were also measured at the LA (18%) and PVA (29%), but not at the RA. AF was associated with a prolonged TAT (p = 0.03) and decreased voltages (P(5)) at BB (p = 0.02). BB was a predilection site for slowing of conduction in patients with AF. Prolonged TAT and decreased voltages were also found at this site. The next step will be to determine the relevance of a reduced CV at BB in relation to AF development and maintenance.
format Online
Article
Text
id pubmed-8231908
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82319082021-06-26 Reduction of Conduction Velocity in Patients with Atrial Fibrillation Heida, Annejet van Schie, Mathijs S. van der Does, Willemijn F. B. Taverne, Yannick J. H. J. Bogers, Ad J. J. C. de Groot, Natasja M. S. J Clin Med Article It is unknown to what extent atrial fibrillation (AF) episodes affect intra-atrial conduction velocity (CV) and whether regional differences in local CV heterogeneities exist during sinus rhythm. This case-control study aims to compare CV assessed throughout both atria between patients with and without AF. Patients (n = 34) underwent intra-operative epicardial mapping of the right atrium (RA), Bachmann’s bundle (BB), left atrium (LA) and pulmonary vein area (PVA). CV vectors were constructed to calculate median CV in addition to total activation times (TAT) and unipolar voltages. Biatrial median CV did not differ between patients with and without AF (90 ± 8 cm/s vs. 92 ± 6 cm/s, p = 0.56); only BB showed a CV reduction in the AF group (79 ± 12 cm/s vs. 88 ± 11 cm/s, p = 0.02). In patients without AF, there was no predilection site for the lowest CV (P(5)) (RA: 12%; BB: 29%; LA: 29%; PVA: 29%). In patients with AF, lowest CV was most often measured at BB (53%) and ranged between 15 to 22 cm/s (median: 20 cm/s). Lowest CVs were also measured at the LA (18%) and PVA (29%), but not at the RA. AF was associated with a prolonged TAT (p = 0.03) and decreased voltages (P(5)) at BB (p = 0.02). BB was a predilection site for slowing of conduction in patients with AF. Prolonged TAT and decreased voltages were also found at this site. The next step will be to determine the relevance of a reduced CV at BB in relation to AF development and maintenance. MDPI 2021-06-14 /pmc/articles/PMC8231908/ /pubmed/34198544 http://dx.doi.org/10.3390/jcm10122614 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Heida, Annejet
van Schie, Mathijs S.
van der Does, Willemijn F. B.
Taverne, Yannick J. H. J.
Bogers, Ad J. J. C.
de Groot, Natasja M. S.
Reduction of Conduction Velocity in Patients with Atrial Fibrillation
title Reduction of Conduction Velocity in Patients with Atrial Fibrillation
title_full Reduction of Conduction Velocity in Patients with Atrial Fibrillation
title_fullStr Reduction of Conduction Velocity in Patients with Atrial Fibrillation
title_full_unstemmed Reduction of Conduction Velocity in Patients with Atrial Fibrillation
title_short Reduction of Conduction Velocity in Patients with Atrial Fibrillation
title_sort reduction of conduction velocity in patients with atrial fibrillation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231908/
https://www.ncbi.nlm.nih.gov/pubmed/34198544
http://dx.doi.org/10.3390/jcm10122614
work_keys_str_mv AT heidaannejet reductionofconductionvelocityinpatientswithatrialfibrillation
AT vanschiemathijss reductionofconductionvelocityinpatientswithatrialfibrillation
AT vanderdoeswillemijnfb reductionofconductionvelocityinpatientswithatrialfibrillation
AT taverneyannickjhj reductionofconductionvelocityinpatientswithatrialfibrillation
AT bogersadjjc reductionofconductionvelocityinpatientswithatrialfibrillation
AT degrootnatasjams reductionofconductionvelocityinpatientswithatrialfibrillation